Anlon Healthcare Limited (NSE:AHCL)

India flag India · Delayed Price · Currency is INR
127.03
-6.96 (-5.19%)
At close: Jan 20, 2026
38.08%
Market Cap6.85B
Revenue (ttm)1.44B
Net Income (ttm)270.26M
Shares Out53.15M
EPS (ttm)6.63
PE Ratio19.45
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume320,139
Average Volume164,028
Open133.99
Previous Close133.99
Day's Range125.44 - 136.07
52-Week Range90.78 - 172.75
Betan/a
RSI35.24
Earnings DateFeb 10, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2013
Employees 117
Stock Exchange National Stock Exchange of India
Ticker Symbol AHCL
Full Company Profile

Financial Performance

In 2024, Anlon Healthcare's revenue was 1.20 billion, an increase of 80.64% compared to the previous year's 666.16 million. Earnings were 205.18 million, an increase of 112.46%.

Financial Statements